US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Adamas Pharmaceuticals Inc (ADMS)
Adamas Pharmaceuticals Inc (ADMS) ニュース

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADMS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/02/15	20 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2022/01/27	01 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/12/10	22 : 53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/12/02	20 : 15	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01 : 54	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01 : 47	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01 : 46	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/25	01 : 43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23 : 28	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23 : 17	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/24	23 : 12	GlobeNewswire Inc.	Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	22 : 22	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	22 : 00	GlobeNewswire Inc.	Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/23	20 : 05	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/18	22 : 58	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/11	06 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/11/02	05 : 55	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/26	06 : 24	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/26	00 : 26	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/25	23 : 22	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/20	05 : 27	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/14	06 : 14	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/12	20 : 56	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc
2021/10/12	20 : 05	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ADMS	Adamas Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:ADMS

1 2 3 4 5 6 7 8 9 10 次へ >>

EUPU24 - Setembro 2024

Essity Ab (publ)

BNP Paribas Issuance

Wyndham Hotels & Resorts

Exela Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約